申请人:The Boots Company PLC
公开号:US04447435A1
公开(公告)日:1984-05-08
Novel quinolones of the general formula ##STR1## wherein n is 0, 1 or 2; R.sub.1 is C.sub.1-4 alkyl; and R.sub.3 is hydrogen, C.sub.1-4 alkyl, methoxy, methylthio, halo or trifluoromethyl. These compounds have antihypertensive activity and may be used for treating hypertension in mammals. The quinolones are administered in novel therapeutic compositions comprising a quinolone of the above general formula together with a pharmaceutically acceptable carrier. Processes for making the novel quinolones are described.
一种新型喹诺酮化合物,其通式为##STR1##其中n为0、1或2;R.sub.1为C.sub.1-4烷基;R.sub.3为氢、C.sub.1-4烷基、甲氧基、甲基硫基、卤素或三氟甲基。这些化合物具有降压活性,可用于治疗哺乳动物的高血压。这些喹诺酮化合物可与药学上可接受的载体一起组成新的治疗组合物进行给药。还描述了制备这些新型喹诺酮化合物的方法。